Stay updated on Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial
Sign up to get notified when there's something new on the Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial page.

Latest updates to the Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial page
- CheckyesterdayChange DetectedMinor history updates: a site-wide funding notice was added and the software version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check8 days agoChange DetectedIntroduced a glossary toggle and color-coded change highlights (green for additions, red for deletions) with an updated revision label (Revision: v3.4.0). The previous revision label (v3.3.4) and the No FEAR Act data entry were removed.SummaryDifference1.0%

- Check15 days agoChange DetectedAdded a Document Section and core study content sections (Contacts/Locations, Eligibility, Arms and Interventions, Study Design, Study Description, Oversight, Study Status) to the Record History page; deleted content on 2025-05-28.SummaryDifference1%

- Check22 days agoChange DetectedRevision history shows that a new revision v3.3.4 was added and an older revision v3.3.3 was removed, which is metadata about the page history rather than the current study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision, v3.3.3, was added to the Record History. The HHS Vulnerability Disclosure link and the older revision v3.3.2 were removed from the footer.SummaryDifference0.2%

- Check66 days agoChange DetectedA minor revision label update was added (Revision: v3.3.2) and a previous label (Revision: v3.3.1) was removed; this does not affect study data or record history details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial page.